市場調査レポート

商品コード

1654282

研究用タンパク質の市場規模、シェア、動向分析レポート：製品別、宿主細胞別、最終用途別、地域別、セグメント別予測、2025年～2030年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product, By Host Cell, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年01月17日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

研究用タンパク質市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の研究用タンパク質市場規模は2030年までに17億5,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 11.49％で成長すると予測されています。がん研究セグメントにおける研究開発への投資の増加や個別化医薬品への需要の高まりが、市場の成長に寄与すると予測されています。また、さまざまな臨床研究のために多くの国で政府投資が増加していることも、市場の成長を促進すると予想されます。さらに、新興諸国におけるバイオテクノロジー産業の進歩の高まりが、予測期間における市場の成長をさらに促進しています。

COVID-19パンデミックは、ワクチン、診断薬、治療開発のための研究活動の急増により、市場にプラスの影響を与えました。規制当局がワクチン候補の承認プロセスを迅速化することに注力したため、受託製造の需要が増加しました。mRNAワクチンのような新規ワクチンプラットフォームは大きな注目を集めたが、組み換えタンパク質ワクチンの代替品もいくつか評価されています。例えば、2022年7月、Novavax, Inc.のCOVID-19ワクチン（NVX-CoV2373）は、EUで使用するための拡大条件付き製造販売承認を取得しました。さらに、パンデミックは、生物製剤における機敏で柔軟な製造能力の必要性を浮き彫りにしました。この要因は、競合情勢を後押しし、近い将来の市場成長を促進すると予想されます。

Global Genesによると、2019年10月、世界では4億人以上の人々が希少疾患や遺伝病を抱えて生活しています。この数字は、治療や臨床環境の改善、健康意識に対する切実なニーズを示しています。先進的な研究と薬剤標的メカニズムの知識が必要であることは、医薬品開発にとって極めて重要です。多くの地域では、コホート・プログラムからバイオバンクを開発し、治療努力に革命を起こすための高品質のサンプルを研究者に提供しています。その結果、様々な疾患に対するバイオマーカー探索への注目が高まると予想されます。このように、より良い医療インフラを構築するための研究活動への取り組みや政府の関心は、研究用タンパク質の応用を強化し、結果として市場の成長を促進すると予想されます。

しかし、タンパク質の生産は時間のかかる作業であり、その過程で作業条件の高い維持管理が必要となることも多いです。これらの組換え製品に対する需要が高く、増え続けているにもかかわらず、規制機関からの支援はまだゆっくりとしたペースで進展しています。研究用のタンパク質は通常、宿主または発現系を介して製造され、目的の製品に特異的な遺伝子が、トランスフェクション、細菌形質転換またはウイルス導入の段階を経て発現されます。この複雑なプロセスは、しばしば標的でない領域の過剰発現という欠点があり、さらに多くの時間を要します。このように、組換え技術に関する特定のガイドラインや規制が存在しないことが、研究用タンパク質市場の活況を妨げる大きな要因となっています。

調査グレードタンパク質市場レポートハイライト

製品別では、サイトカインと成長因子セグメントが2024年に23.61％の最大収益シェアで市場を独占し、予測期間中に17.62％の最速CAGRで成長すると予測されています。これは、創薬と開発のための様々な臨床検査における役割に起因しています。
宿主細胞別では、哺乳類細胞セグメントは2024年に55.73%の最大収益シェアで市場を独占しました。この大きなシェアは、主にヒト細胞と生物学的構造が似ているためで、モノクローナル抗体やワクチンなどのバイオ医薬品の生産に役立っています。
最終用途別では、製薬・バイオテクノロジー企業が2024年に61.48%の最大シェアを占めました。創薬開発のための研究活動の増加や個別化医薬品の需要の増加により、研究用タンパク質の需要は予測期間中に増加すると予測されています。
地域別では、北米が2024年の売上高シェア44.47%で市場を独占しています。この大きなシェアは、大手市場参入企業の存在と強固な医療インフラに起因しています。これらの要因は、予測期間中に同地域の研究用タンパク質市場を押し上げると予測されています。

製品セグメントダッシュボード
研究用タンパク質市場：製品変動分析
世界のリサーチグレードタンパク質市場規模と動向分析、製品別、2018～2030年
サイトカインと成長因子
- サイトカインと成長因子市場、2018～2030年
- インターフェロン（IFN）
- インターロイキン（IL）
- その他
抗体
- 抗体、2018～2030年
免疫チェックポイントタンパク質
- 免疫チェックポイントタンパク質市場、2018～2030年
ウイルス抗原
- ウイルス抗原市場、2018～2030年
酵素
- 酵素市場、2018～2030年
- キナーゼ
- 代謝酵素
- その他
組み換え調節タンパク質
- 組み換え調節タンパク質市場、2018～2030年
ホルモン
- ホルモン市場、2018～2030年
その他
- その他市場、2018～2030年

第5章宿主細胞ビジネス分析

宿主細胞セグメントダッシュボード
研究用タンパク質市場：宿主細胞変動分析
世界の研究用タンパク質市場規模と動向分析、宿主細胞別、2018～2030年
哺乳類細胞
- 哺乳類細胞市場、2018～2030年
細菌細胞
- 細菌細胞市場、2018～2030年
酵母と菌類
- 酵母と菌類市場、2018～2030年
昆虫細胞
- 昆虫細胞市場、2018～2030年
その他
- その他市場、2018～2030年

第6章最終用途ビジネス分析

最終用途セグメントダッシュボード
研究用タンパク質市場：最終用途変動分析
世界のリサーチグレードタンパク質市場規模と動向分析、最終用途別、2018～2030年
製薬・バイオテクノロジー企業
- 製薬・バイオテクノロジー企業市場、2018～2030年
学術研究機関
- 学術研究機関市場、2018～2030年
その他
- その他市場、2018～2030年

第7章地域ビジネス分析

地域ダッシュボード
市場規模と予測と動向分析、2018～2030年
北米
- 北米の研究用タンパク質市場、2018～2030年
- 米国
- カナダ
欧州
- 欧州の研究用タンパク質市場、2018～2030年
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- アジア太平洋の研究用タンパク質市場、2018～2030年
- 日本
- 中国
- インド
- 韓国
- タイ
- オーストラリア
ラテンアメリカ
- ラテンアメリカの研究用タンパク質市場、2018～2030年
- ブラジル
- アルゼンチン
中東・アフリカ
- 中東・アフリカの研究用タンパク質市場、2018～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第8章競合情勢

企業分類
戦略マッピング
Company Position Analysis, 2024
企業プロファイル/上場企業
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- Miltenyi BIoTec
- GenScript
- Bio-Techne
- Proteintech Group, Inc.
- ACROBiosystems
- Sino Biological, Inc.
- ProSpec-Tany TechnoGene Ltd.
- New England Biolabs

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 6 North America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 9 U.S research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 12 Canada research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 13 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 15 Mexico research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 16 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 17 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 18 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 19 Europe research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 20 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 21 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 22 UK research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 24 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 25 Germany research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 26 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 27 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 28 France research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 29 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 30 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 31 Italy research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 32 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 33 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 34 Spain research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 35 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 37 Denmark research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 38 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 40 Sweden research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 41 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 42 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 43 Norway research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 44 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 47 Asia Pacific research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 48 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 49 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 50 China research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 52 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 53 Japan research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 54 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 55 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 56 India research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 57 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 58 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 59 South Korea research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 61 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 62 Australia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 63 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 64 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 65 Thailand research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 66 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 69 Latin America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 70 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 72 Brazil research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 75 Argentina research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 82 South Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 88 UAE research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 91 Kuwait research-grade proteins market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global research-grade proteins market- Key market driver analysis
Fig. 7 Global research-grade proteins market - Key market restraint analysis
Fig. 8 Global research-grade proteins market - Porter's analysis
Fig. 9 Global research-grade proteins market - PESTEL analysis
Fig. 10 Global research-grade proteins market: Product outlook key takeaways
Fig. 11 Global research-grade proteins market: Product movement analysis
Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
Fig. 27 Global research-grade proteins market: Host cells movement analysis
Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
Fig. 33 Global research-grade proteins market: End use outlook key takeaways
Fig. 34 Global research-grade proteins market: End use movement analysis
Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global research-grade proteins market: Regional movement analysis
Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 43 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 44 Europe research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 45 UK research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 46 Germany research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 47 France research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 48 Spain research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 49 Italy research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 50 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 51 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 52 Norway research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 54 Japan research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 55 China research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 56 India research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 57 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 58 Australia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 59 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 60 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 61 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 68 Strategy framework

Product Code: GVR-4-68040-130-6

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is anticipated to reach USD 1.75 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.49% from 2025 to 2030. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.61% in 2024 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2024. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.48% in 2024. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
Based on region, North America dominated the market with a revenue share of 44.47% in 2024. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Chapter 1. Research-grade Proteins Market: Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Host Cell Segment
- 1.2.3. End Use Segment
1.3. Research Assumptions
1.4. Information Procurement
- 1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives

Chapter 2. Research-grade Proteins Market: Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
  - 3.3.1.1. Increasing use of recombinant proteins in research activities
  - 3.3.1.2. Growing research activities for drug discovery and precision medicine
  - 3.3.1.3. Rising adoption of biologics & biosimilars
- 3.3.2. Market Restraint Analysis
  - 3.3.2.1. Regulatory and safety concerns regarding protein production
  - 3.3.2.2. Dearth of skilled personnel and expertise
3.4. Business Environment Analysis
- 3.4.1. PESTEL Analysis
- 3.4.2. Porter's Five Forces Analysis
- 3.4.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

4.1. Product Segment Dashboard
4.2. Research-grade Proteins Market: Product Movement Analysis
4.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Cytokines & Growth Factors
- 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
- 4.4.2. Interferons (IFNs)
  - 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
- 4.4.3. Interleukins (ILs)
  - 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
4.5. Antibodies
- 4.5.1. Antibodies, 2018 - 2030 (USD Million)
4.6. Immune Checkpoint Proteins
- 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
4.7. Virus Antigens
- 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
4.8. Enzymes
- 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
- 4.8.2. Kinases
  - 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
- 4.8.3. Metabolic Enzymes
  - 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
- 4.8.4. Others
  - 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
4.9. Recombinant Regulatory Proteins
- 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
4.10. Hormones
- 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
4.11. Others
- 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

5.1. Host Cell Segment Dashboard
5.2. Research-grade Proteins Market: Host Cell Movement Analysis
5.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
5.4. Mammalian Cells
- 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
5.5. Bacterial Cells
- 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
5.6. Yeast & Fungi
- 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
5.7. Insect Cells
- 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

6.1. End Use Segment Dashboard
6.2. Research-grade Proteins Market: End Use Movement Analysis
6.3. Global Research-Grade Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.5. Academic & Research Institutes
- 6.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
- 7.3.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4. Europe
- 7.4.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.4. Spain
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.5. France
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.6. Italy
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.5.7. Australia
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6. Latin America
- 7.6.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7. MEA
- 7.7.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific, Inc.
  - 8.4.1.1. Company Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Abcam Plc
  - 8.4.2.1. Company Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Miltenyi Biotec
  - 8.4.3.1. Company Overview
  - 8.4.3.2. Product Benchmarking
  - 8.4.3.3. Strategic Initiatives
- 8.4.4. GenScript
  - 8.4.4.1. Company Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Bio-Techne
  - 8.4.5.1. Company Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Proteintech Group, Inc.
  - 8.4.6.1. Company Overview
  - 8.4.6.2. Product Benchmarking
  - 8.4.6.3. Strategic Initiatives
- 8.4.7. ACROBiosystems
  - 8.4.7.1. Company Overview
  - 8.4.7.2. Product Benchmarking
  - 8.4.7.3. Strategic Initiatives
- 8.4.8. Sino Biological, Inc.
  - 8.4.8.1. Company Overview
  - 8.4.8.2. Product Benchmarking
  - 8.4.8.3. Strategic Initiatives
- 8.4.9. ProSpec-Tany TechnoGene Ltd.
  - 8.4.9.1. Company Overview
  - 8.4.9.2. Product Benchmarking
  - 8.4.9.3. Strategic Initiatives
- 8.4.10. New England Biolabs
  - 8.4.10.1. Company Overview
  - 8.4.10.2. Product Benchmarking
  - 8.4.10.3. Strategic Initiatives

研究用タンパク質の市場規模、シェア、動向分析レポート：製品別、宿主細胞別、最終用途別、地域別、セグメント別予測、2025年～2030年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product, By Host Cell, By End-use, By Region, And Segment Forecasts, 2025 - 2030

研究用タンパク質市場の成長と動向

調査グレードタンパク質市場レポートハイライト

目次

第1章研究用タンパク質市場：調査手法と範囲

第2章研究用タンパク質市場：エグゼクティブサマリー

第3章研究用タンパク質市場の変数、動向、範囲

第4章製品ビジネス分析

第5章宿主細胞ビジネス分析

第6章最終用途ビジネス分析

第7章地域ビジネス分析

第8章競合情勢

List of Tables

List of Figures

Research-grade Proteins Market Growth & Trends:

Research-grade Proteins Market Report Highlights:

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

Chapter 2. Research-grade Proteins Market: Executive Summary

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Host Cell Business Analysis

Chapter 6. End Use Business Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

研究用タンパク質の市場規模、シェア、動向分析レポート：製品別、宿主細胞別、最終用途別、地域別、セグメント別予測、2025年～2030年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product, By Host Cell, By End-use, By Region, And Segment Forecasts, 2025 - 2030

研究用タンパク質市場の成長と動向

調査グレードタンパク質市場レポートハイライト

目次

第1章 研究用タンパク質市場：調査手法と範囲

第2章 研究用タンパク質市場：エグゼクティブサマリー

第3章 研究用タンパク質市場の変数、動向、範囲

第4章 製品ビジネス分析

第5章 宿主細胞ビジネス分析

第6章 最終用途ビジネス分析

第7章 地域ビジネス分析

第8章 競合情勢

List of Tables

List of Figures

Research-grade Proteins Market Growth & Trends:

Research-grade Proteins Market Report Highlights:

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

Chapter 2. Research-grade Proteins Market: Executive Summary

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Host Cell Business Analysis

Chapter 6. End Use Business Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

第1章研究用タンパク質市場：調査手法と範囲

第2章研究用タンパク質市場：エグゼクティブサマリー

第3章研究用タンパク質市場の変数、動向、範囲

第4章製品ビジネス分析

第5章宿主細胞ビジネス分析

第6章最終用途ビジネス分析

第7章地域ビジネス分析

第8章競合情勢